FDA Inspection 1027102 — Oklahoma Blood Institute Texas Blood Institute
The FDA completed an inspection of Oklahoma Blood Institute Texas Blood Institute on September 22, 2017 in Wichita Falls, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 22, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Wichita Falls, TX (United States)